SCHEMBL23837357

SCHEMBL23837357

CC(=O)N[C@H]1Cc2cc(Cl)c(Cl)c(C(=O)O)c2OB1N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23837496 0.86 MTNR1A (0.31) —
SCHEMBL17347833 0.85 CAT (0.30) —
SCHEMBL23837348 0.74 CA12 (0.30) —
SCHEMBL23130239 0.73 MTNR1A (0.30) —
SCHEMBL17347791 0.73 MTNR1A (0.30) —
SCHEMBL17347778 0.73 — —
SCHEMBL23130252 0.72 OPRK1 (0.34) —
SCHEMBL17347653 0.72 MTNR1A (0.33) —
SCHEMBL17347774 0.70 CAT (0.33) —
SCHEMBL23130010 0.70 CAT (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback